David Vocadlo is a Canada Research Chair (CRC) in chemical glycobiology and professor in the Departments of Chemistry and Molecular Biology and Biochemistry at Simon Fraser University (SFU).
Vocadlo completed his PhD in biological chemistry at the University of British Columbia in 2002. He was a Canadian Institutes of Health Research post-doctoral fellow at the University of California at Berkeley in the Departments of Chemistry and Molecular and Cell Biology. Returning to Canada in 2004, he joined SFU where he is a professor in the Departments of Chemistry and Molecular Biology and Biochemistry. Vocadlo and the laboratory of Chemical Glycobiology that he heads have been recognized with several awards including the EWR Steacie Fellowship, Canada’s Top 40 Under 40 Award and The Horace Isbell Award of the American Chemical Society. He has authored over 90 papers and is an inventor on over a dozen patents. He is also a founder of Alectos Therapeutics, a biotechnology company dedicated to the development of small-molecule therapeutics. He and his team are striving to develop chemical tools for probing and perturbing carbohydrate structures as well as to use these tools to understand the roles of these glycans within cellular and organismal models.